Table 1.
Characteristics | Overall |
---|---|
n = 1,494 | |
Demographic data | |
Age, years | 70.76 (5.16) |
Gender, male | 951(63.65%) |
BMI, kg/m2 | 22.58 (3.55) |
Smoking, yes | 696 (46.59%) |
Alcohol, yes | 289 (19.34%) |
Comorbidities | |
Absent | 1,081 (72.36%) |
Hypertension | 337 (22.56%) |
Others | 76 (5.09%) |
Disease data | |
Tumor location | |
Lung | 458 (30.66%) |
Digestive | 759 (50.80%) |
Other | 277 (18.54%) |
Tumor stage: | |
I | 147 (9.84%) |
II | 336 (22.49%) |
III | 373 (24.97%) |
IV | 638 (42.70%) |
Chemotherapy, yes | 939 (62.85%) |
Radiotherapy, yes | 1,494(100.00%) |
Immunotherapy, yes | 109 (7.30%) |
Surgery, yes | 357 (23.90%) |
ECOG | 1.09 (0.80) |
Laboratory data | |
Albumin, g/dl | 3.80 (0.53) |
Cholesterol, mg/dl | 182.95 (60.94) |
Lymphocyte, *109/L | 1.67 (1.37) |
Nutritional data | |
CONUT, as continuous | 2.30 (2.21) |
Category | |
Absent | 672 (44.98%) |
Mild | 602 (40.29%) |
Moderate | 193 (12.92%) |
Severe | 27 (1.81%) |
PNI, as continuous | 46.05 (9.90) |
Category | |
Absent | 1,320 (88.35%) |
Moderate | 77 (5.15%) |
Severe | 97 (6.49%) |
NRI, as continuous | 96.96 (10.32) |
Category | |
Absent | 617 (41.30%) |
Mild | 174 (11.65%) |
Moderate | 607 (40.63%) |
Severe | 96 (6.43%) |
PG-SGA, as continuous | 6.26 (4.48) |
Category | |
Absent | 52 (3.48%) |
Mild | 503 (33.67%) |
Moderate | 549 (36.75%) |
Severe | 390 (26.10%) |
HGS, kg | 22.38 (8.93) |
EORTCQLQ-C30 | 39.21 (4.79) |
PN, yes | 188 (12.58%) |
EN, yes | 146 (9.77%) |
Values are mean (SD) or n (%). BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; CONUT, Controlling Nutritional Status score; PNI, prognostic nutritional index; NRI, nutritional risk index; PG-SGA, a patient-generated subjective global assessment; HGS, handgrip strength; EORTCQLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; PN, parenteral nutrition; EN, enteral nutrition.